Sennosides Market

Sennosides sales will expand through 2035, with sennosides at 67.0% and mixed formulations at 32.0% of drug type demand in 2025. The market was valued at USD 391.08 million in 2025, is projected to reach USD 584.48 million by 2035 and is forecast to record a 4.1% CAGR between 2025 and 2035.